+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Ichthyosis - Pipeline Insight, 2025 - Product Thumbnail Image

Ichthyosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Palmoplantar Pustulosis - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Pustulosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Palmoplantar Keratoderma - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Keratoderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Scars - Pipeline Insight, 2025 - Product Thumbnail Image

Scars - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Palmar Hyperhidrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Palmar Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Axillary Hyperhidrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Axillary Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Uremic Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Uremic Pruritus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Eczema- Pipeline Insight, 2025 - Product Thumbnail Image

Eczema- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Cholestatic Pruritus- Pipeline Insight, 2025 - Product Thumbnail Image

Cholestatic Pruritus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Idiopathic Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Nail Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Nail Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Bacterial Skin Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Skin Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Common Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Common Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025 - Product Thumbnail Image

Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more